IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-024-55029-9.html
   My bibliography  Save this article

Strength and durability of indirect protection against SARS-CoV-2 infection through vaccine and infection-acquired immunity

Author

Listed:
  • Sophia T. Tan

    (Stanford University)

  • Isabel Rodríguez-Barraquer

    (University of California)

  • Ada T. Kwan

    (University of California)

  • Seth Blumberg

    (University of California
    University of California)

  • Hailey J. Park

    (Stanford University)

  • Justine Hutchinson

    (California Correctional Health Care Services)

  • David Leidner

    (California Department of Corrections and Rehabilitation)

  • Joseph A. Lewnard

    (University of California
    University of California
    University of California)

  • David Sears

    (University of California)

  • Nathan C. Lo

    (Stanford University)

Abstract

Early investigation revealed a reduced risk of SARS-CoV-2 infection among social contacts of COVID-19 vaccinated individuals, referred to as indirect protection. However, indirect protection from SARS-CoV-2 infection-acquired immunity and its comparative strength and durability to vaccine-derived indirect protection in the current epidemiologic context of high levels of vaccination, prior infection, and novel variants are not well characterized. Here, we show that both vaccine-derived and infection-acquired immunity independently yield indirect protection to close social contacts with key differences in their strength and waning. Analyzing anonymized SARS-CoV-2 surveillance data from 9,625 residents in California state prisons from December 2021 to December 2022, we find that vaccine-derived indirect protection against Omicron SARS-CoV-2 infection is strongest within three months of COVID-19 vaccination [30% (95% confidence interval: 20–38%)] with subsequent modest protection. Infection-acquired immunity provides 38% (24–50%) indirect protection for 6 months after SARS-CoV-2 infection, with moderate indirect protection persisting for over one year. Variant-targeted vaccines (bivalent formulation including Omicron subvariants BA.4/BA.5) confer strong indirect protection for at least three months [40% (3–63%)]. These results demonstrate that both vaccine-derived and infection-acquired immunity can reduce SARS-CoV-2 transmission which is important for understanding long-term transmission dynamics and can guide public health intervention, especially in high-risk environments such as prisons.

Suggested Citation

  • Sophia T. Tan & Isabel Rodríguez-Barraquer & Ada T. Kwan & Seth Blumberg & Hailey J. Park & Justine Hutchinson & David Leidner & Joseph A. Lewnard & David Sears & Nathan C. Lo, 2025. "Strength and durability of indirect protection against SARS-CoV-2 infection through vaccine and infection-acquired immunity," Nature Communications, Nature, vol. 16(1), pages 1-10, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-024-55029-9
    DOI: 10.1038/s41467-024-55029-9
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-55029-9
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-024-55029-9?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Frederik Plesner Lyngse & Laust Hvas Mortensen & Matthew J. Denwood & Lasse Engbo Christiansen & Camilla Holten Møller & Robert Leo Skov & Katja Spiess & Anders Fomsgaard & Ria Lassaunière & Morten Ra, 2022. "Household transmission of the SARS-CoV-2 Omicron variant in Denmark," Nature Communications, Nature, vol. 13(1), pages 1-7, December.
    2. Lior Rennert & Zichen Ma & Christopher S. McMahan & Delphine Dean, 2022. "Effectiveness and protection duration of Covid-19 vaccines and previous infection against any SARS-CoV-2 infection in young adults," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    3. Jussipekka Salo & Milla Hägg & Mika Kortelainen & Tuija Leino & Tanja Saxell & Markku Siikanen & Lauri Sääksvuori, 2022. "The indirect effect of mRNA-based COVID-19 vaccination on healthcare workers’ unvaccinated household members," Nature Communications, Nature, vol. 13(1), pages 1-7, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Denis Mongin & Nils Bürgisser & Gustavo Laurie & Guillaume Schimmel & Diem-Lan Vu & Stephane Cullati & Delphine Sophie Courvoisier, 2023. "Effect of SARS-CoV-2 prior infection and mRNA vaccination on contagiousness and susceptibility to infection," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    2. Alessia Raineri & Thomas Radtke & Sonja Rueegg & Sarah R. Haile & Dominik Menges & Tala Ballouz & Agne Ulyte & Jan Fehr & Daniel L. Cornejo & Giuseppe Pantaleo & Céline Pellaton & Craig Fenwick & Milo, 2023. "Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    3. Xueyi Hu & Yichun Wang & Ruohan Wang & Yiyao Pu & Rongrong Jin & Yu Nie & Xintao Shuai, 2025. "The hybrid lipoplex induces cytoskeletal rearrangement via autophagy/RhoA signaling pathway for enhanced anticancer gene therapy," Nature Communications, Nature, vol. 16(1), pages 1-20, December.
    4. Amanda C. Perofsky & Chelsea L. Hansen & Roy Burstein & Shanda Boyle & Robin Prentice & Cooper Marshall & David Reinhart & Ben Capodanno & Melissa Truong & Kristen Schwabe-Fry & Kayla Kuchta & Brian P, 2024. "Impacts of human mobility on the citywide transmission dynamics of 18 respiratory viruses in pre- and post-COVID-19 pandemic years," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    5. Julia R. Port & Claude Kwe Yinda & Jade C. Riopelle & Zachary A. Weishampel & Taylor A. Saturday & Victoria A. Avanzato & Jonathan E. Schulz & Myndi G. Holbrook & Kent Barbian & Rose Perry-Gottschalk , 2023. "Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamsters," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    6. Rafael R. G. Machado & Jordyn L. Walker & Dionna Scharton & Grace H. Rafael & Brooke M. Mitchell & Rachel A. Reyna & William M. Souza & Jianying Liu & David H. Walker & Jessica A. Plante & Kenneth S. , 2023. "Immunogenicity and efficacy of vaccine boosters against SARS-CoV-2 Omicron subvariant BA.5 in male Syrian hamsters," Nature Communications, Nature, vol. 14(1), pages 1-13, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-024-55029-9. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.